Biosensors have the potential to make a tremendous contribution to clinical trials, providing the researchers with data that can be automatically transmitted and instantly analyzed via mobile technologies. Furthermore, patient’s symptoms can be monitored and can trigger a series of notifications, flags and calls to action to resolve any potential issues the patient may be experiencing before they have negative health effects.
While biosensors are very convenient for obtaining physiological data, the context under which such physiological parameters are recorded is critical to properly understanding the patient’s condition. This is where electronic patient diaries (eDiary) or electronic Patient Reported Outcomes (ePRO) become an integral part of mobile health (mHealth).
Although the idea of combining the technology of patient diaries (ePRO) and biosensors is extremely attractive for clinical trials, a number of hurdles need to be overcome for widespread usage. This Applied Clinical Trials article discusses the potential of biosensors and mobile technologies in clinical trials, outlining the key advantages as well as the challenges of implementation in an environment with rigorous laws and regulations.